Harnessing computation to radically improve lives.

Read our story

[data-wf-bgvideo-fallback-img] { display: none; } @media (prefers-reduced-motion: reduce) { [data-wf-bgvideo-fallback-img] { position: absolute; z-index: -100; display: inline-block; height: 100%; width: 100%; object-fit: cover; } }

Pushing the boundaries of AI in drug discovery.

Valence Labs is a research engine committed to advancing the frontier of AI in drug discovery.

We develop novel AI technologies to spearhead a fundamental shift in the way we discover and develop treatments for complex disease. Our research is driven by optimism, purpose, and the shared vision of a healthier tomorrow.

Together, we are harnessing computation to radically improve lives.

Latest Updates

Catch up on the latest from Valence Labs.

July 26, 2023

Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

July 12, 2023

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

May 8, 2023

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

Research

July 14, 2023

Graph Positional and Structural Encoder

June 7, 2023

Goal-conditioned GFlowNets for Controllable Multi-Objective Molecular Design

June 5, 2023

Real-World Molecular Out-Of-Distribution: Specification and Investigation

May 11, 2023

Towards Understanding and Improving GFlowNet Training

March 6, 2023

MoDTI: Modular Framework For Evaluating Inductive Biases in DTI Modeling

March 6, 2023

Task-Agnostic Graph Neural Network Evaluation via Adversarial Collaboration

February 11, 2023

Sequential Underspecified Instrument Selection for Cause-Effect Estimation

February 9, 2023

Helixer–de novo Prediction of Primary Eukaryotic Gene Models Combining Deep Learning and a Hidden Markov Model

February 8, 2023

DynGFN: Bayesian Dynamic Causal Discovery Using Generative Flow Networks

February 1, 2023

GFlowNets for AI-driven Scientific Discovery

Learn more

Valence Portal coming soon.

Valence is committed to open science and open source. Stay tuned for the launch of Valence Portal, the new home for the AI x drug discovery community.

Subscribe to our newsletter

Careers @ Valence Labs

Unleash your potential and build the future of drug discovery at Valence Labs. Explore open opportunities now.

Apply